The aim of this study was evaluate the effect of prolonged use of high dose of tibolone on the vagina of ovariectomized rats. Bilateral ovariectomy was performed on 14 rats weighing 250 g. Thirty days later, vaginal smears were collected verifying the menopause status by anoestrus cytology. Rats were divided randomly into groups: experimental rats (n = 9) received 1 mg tibolone/day orally and control rats (n = 6) received placebo (carboxymethylcellulose). After 150 days, all rats were sedated and euthanized by cervical displacement. The vagina was removed, fixed in 10% buffered formalin, sampled and processed for paraffin embedding. Histological sections were stained with haematoxylin and eosin, picrosirius red, periodic acid Schiff (PAS) and PAS-diastase, and Weigert's resorcin-fuchsin. Cell proliferation was analysed by immunohistochemistry to detect Ki67. Histomorphometric analyses were performed for epithelial thickness, per cent area of collagen fibres and blood vessels, mast cells and Ki67-positive nuclei per mm of basal membrane. Means and standard error of means were calculated, and data were compared using the Mann-Whitney test, with significance level at P < 0.05. In the vagina, epithelial thickness, number of Ki67-positive nuclei per mm of basal membrane, number of vessels and number of mast cells were significantly higher in the tibolone group when compared with the control group. Furthermore, the content of glycogen and glycoproteins in the vaginal epithelium was modified by tibolone. Tibolone administered in high dose and for a long period has a trophic effect, reversing vaginal atrophy, and has no dysplastic or neoplastic effect in the vagina of ovariectomized rats.

tibolone causes a significant reduction of HDL-c and total cholesterol and has a deleterious effect on the body weight of oophorectomized rats, which may be related to the lower food ingestion by these animals.

Introdução e objetivo: O efeito da tibolona utilizada em alta dose e por tempo prolongado foi analisado mediante estudo histomorfométrico de tíbias e fêmures de ratas castradas. Métodos: O experimento utilizou 20 ratas Wistar, com peso médio de 250 g. Os animais foram distribuídos aleatoriamente em três grupos: ooforectomizado recebendo tibolona (OVX + T) (n = 9), ooforectomizado (OVX) (n = 6) e grupo controle não ooforectomizado (C) (n = 5). Deu-se início ao protocolo experimental 30 dias após a ooforectomia, perdurando por 20 semanas, com administração de tibolona (1 mg/dia) a OVX + T e carboximetilcelulose a OVX. O grupo C não foi submetido a qualquer tratamento. Tíbias e fêmures direitos foram fixados em formol a 10% tamponado, descalcificados e processados para inclusão em parafina. Os cortes histológicos foram corados mediante hematoxilina-eosina para análise histomorfométrica. Mediram-se a espessura cortical e a cavidade medular em cortes transversais de tíbia e fêmur e percentual de porosidade e densidade trabecular em cortes longitudinais de fêmur. Resultados e discussão: Não houve diferença estatística entre OVX e OVX + T nas diversas análises. Os resultados demonstram que a tibolona não melhorou de forma significativa a qualidade óssea, porém preservou a massa óssea cortical, nas diáfises femoral e tibial, e o osso trabecular, nos côndilos femorais. O uso prolongado de tibolona em concomitância com alta dose pode ter influenciado tais efeitos, já que estudos recentes têm preconizado a utilização de doses mais baixas na prevenção da osteoporose. Conclusão: A ooforectomia ocasionou perda óssea nas regiões analisadas; a tibolona, apesar de não ter aumentado a massa óssea, manteve-a em níveis satisfatórios. . The animals were randomly divided into three groups: oophorectomized receiving tibolone (OVX + T) (n = 9), oophorectomized (OVX) (n = 6) and non-oophorectomized as control group (C) (n = 5). The experimental protocol was initiated 30 days after oophorectomy and lasted 20 weeks. Tibolone (1 mg/day) was administered to OVX + T rats and carboxymethyl cellulose to OVX. C rats did not go through any treatment. Right side tibias and femurs

high doses of tibolone, given for long periods of time to castrated female rats, have an estrogenic effect which can be dose-dependent, causing proliferation in the endometrium and causing changes in the cell differentiation (squamous metaplasia), but do not lead to hyperplasia.

PURPOSE: To verify the effects of tibolone administration on trabecular and cortical bone of ovariectomized female rats by computed radiography system (CRS). METHODS: The experiment was performed on two groups of rats previously ovariectomized, one received tibolone (OVX+T) while the other did not (OVX), those groups were compared to a control group (C) not ovariectomized. Tibolone administration (1mg/day) began thirty days after the ovariectomy and the treatment remained for five months. At last, the animals were euthanized and femurs and tibias collected. Computed radiographies of the bones were obtained and the digital images were used to determine the bone optical density and cortical thickness on every group. All results were statistically evaluated with significance set at P<0.05%. RESULTS: Tibolone administration was shown to be beneficial only in the densitometric analysis of the femoral head, performing higher optical density compared to OVX. No difference was found in cortical bone thickness. CONCLUSION: Ovariectomy caused bone loss in the analyzed regions and tibolone administered in high doses over a long period showed not to be fully beneficial, but preserved bone mass in the femoral head.